DOI: 10.1007/bf00431840. Effect of baclofen on tardive dyskinesia

Effect of baclofen on tardive dyskinesia

10.1007/bf00431840

Crossref journal-article

Springer Science and Business Media LLC

Psychopharmacology (297)

Bibliography

Gerlach, J., Rye, T., & Kristjansen, P. (1978). Effect of baclofen on tardive dyskinesia. Psychopharmacology, 56(2), 145â151.

Authors 3

J. Gerlach (first)
T. Rye (additional)
P. Kristjansen (additional)

References 31 Referenced 55

American College of Neuropsychopharmacology-Food and Drug Administration Task Force: Neurological syndromes associated with antipsychotic drug use. Arch. Gen. Psychiatry 28, 463?467 (1973) (10.1001/archpsyc.1973.01750340009001) / Arch. Gen. Psychiatry by American College of Neuropsychopharmacology-Food and Drug Administration Task Force (1973)
Andén, N. E., Dalén, P., Johansson, B.: Baclofen and lithium in Huntington's chorea. Lancet 1973II, 93 (10.1016/S0140-6736(73)93285-6)
Andén, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 297, 89?92 (1973) (10.1007/BF00502071) / Naunyn Schmiedebergs Arch. Pharmacol. by N. E. Andén (1973)
Andén, N. E., Wachtel, H.: Biochemical effects of baclofen (?-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain. Acta Pharmacol. Toxicol. (Kbh.) 40, 310?320 (1977) (10.1111/j.1600-0773.1977.tb02083.x) / Acta Pharmacol. Toxicol. (Kbh.) by N. E. Andén (1977)
Ayd, F. J., Jr.: Persistent dyskinesia: a neurologic complication of major tranquilizers. Med. Sci. 18, 32?40 (1967) / Med. Sci. by F. J. Ayd Jr. (1967)
Chase, T. N., Walters, J. R.: Pharmacologic approach to the manipulation of GABA mediated synaptic function man. In: GABA in nervous system function. E. Roberts and T. N. Chase, eds., pp. 497?513. New York: Raven Press 1976 / GABA in nervous system function by T. N. Chase (1976)
Claveria, L. E., Teychenne, P. F., Calne, D. B., Haskayne, L., Petrie, A., Pallis, C. A., Lodge-Patch, I. C.: Tardive dyskinesia treated with pimozide. J. Neurol. Sci. 24, 393?401 (1975) (10.1016/0022-510X(75)90165-3) / J. Neurol. Sci. by L. E. Claveria (1975)
Costall, B., Naylor, R. J., Pinder, R. M.: Mechanisms of dyskinesia in induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat. Neuropharmacology 15, 203?210 (1976) (10.1016/0028-3908(76)90030-7) / Neuropharmacology by B. Costall (1976)
Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am. J. Psychiatry 124, 40?48 (1968) (10.1176/ajp.124.8S.40) / Am. J. Psychiatry by G. E. Crane (1968)
Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395?405 (1973) (10.1192/bjp.122.4.395) / Br. J. Psychiatry by G. E. Crane (1973)
Davis, K. L., Hollister, L. E., Berger, P. A.: Baclofen in schizophrenia. Lancet 1976I, 1245 (10.1016/S0140-6736(76)92198-X)
Fuxe, K., Hökfelt, T., Ljungdahl, Å, Agnati, L., Johansson, O., de la Mora, M.: Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177?183 (1975) / Med. Biol. by K. Fuxe (1975)
Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.) 34, 21?35 (1974) (10.1007/BF00421217) / Psychopharmacologia (Berl.) by J. Gerlach (1974)
Gerlach, J., Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int. Pharmacopsychiatry 11, 1?7 (1976) (10.1159/000468206) / Int. Pharmacopsychiatry by J. Gerlach (1976)
Gulman, N. C., Bahr, B., Andersen, B., Eliassen, H. M.: A doubleblind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr. Scand 54, 287?293 (1976) (10.1111/j.1600-0447.1976.tb00122.x) / Acta Psychiatr. Scand by N. C. Gulman (1976)
Hattori, T., McGeer, P. L., Fibiger, H. H., McGeer, E. G.: On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. Brain Res. 54, 103?114 (1973) (10.1016/0006-8993(73)90037-1) / Brain Res. by T. Hattori (1973)
Honigfeld, G., Klett, C. J.: The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia. J. Clin. Psychol. 21, 65?71 (1965) (10.1002/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I) / J. Clin. Psychol. by G. Honigfeld (1965)
Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch. Gen. Psychiatry 27, 95?99 (1972a) (10.1001/archpsyc.1972.01750250081011) / Arch. Gen. Psychiatry by H. Kazamatsuri (1972)
Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate. Arch. Gen. Psychiatry 27, 100?103 (1972b) (10.1001/archpsyc.1972.01750250086012) / Arch. Gen. Psychiatry by H. Kazamatsuri (1972)
Korsgaard, S.: Baclofen (Lioresal®) in the treatment of neurolepticinduced tardive dyskinesia. Acta Psychiatr. Scand. 54, 17?24 (1976) (10.1111/j.1600-0447.1976.tb00090.x) / Acta Psychiatr. Scand. by S. Korsgaard (1976)
Lahti, R. A., Losey, E. G.: Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA. Res. Commun. Chem. Pathol. Pharmacol. 7, 31?40 (1974) / Res. Commun. Chem. Pathol. Pharmacol. by R. A. Lahti (1974)
Linnoila, M., Viukari, M., Hietala, O.: Effects of sodium valproate on tardive dyskinesia. Br. J. Psychiatry 129, 114?119 (1976) (10.1192/bjp.129.2.114) / Br. J. Psychiatry by M. Linnoila (1976)
McKenzie, G. M., Viik, K.: Chemically induced choreiform activity: antagonism by GABA and EEG patterns. Exp. Neurol. 46, 229?243 (1975) (10.1016/0014-4886(75)90045-X) / Exp. Neurol. by G. M. McKenzie (1975)
Naik, S. R., Guidotto, A., Costa, E.: Central GABA receptor agonists: comparison of muscimol and baclofen. Neuropharmacology 15, 479?484 (1976) (10.1016/0028-3908(76)90058-7) / Neuropharmacology by S. R. Naik (1976)
Overall, J. E., Gorham, D. R.: The brief psychiatric rating scale. Psychol. Rep. 10, 799?812 (1962) (10.2466/pr0.1962.10.3.799) / Psychol. Rep. by J. E. Overall (1962)
Perry, T. L., Hansen, S., Kloster, M.: Huntington's chorea: deficiency of ?-aminobutyric acid in brain. N. Engl. J. Med. 228, 337?342 (1973) (10.1056/NEJM197302152880703) / N. Engl. J. Med. by T. L. Perry (1973)
Simpson, G. M., Branchey, M. H., Shrivastava, R. K.: Baclofen in schizophrenia. Lancet 1976I, 967?968 (10.1016/S0140-6736(76)92749-5)
Villeneuve, A., Böszörményi, Z: Treatment of drug-induced dyskinesias. Lancet 1970I, 353?354 (10.1016/S0140-6736(70)90724-5)
Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigroneostriatal pathways. J. Pharmacol. Exp. Ther. 186, 630?639 (1973) / J. Pharmacol. Exp. Ther. by J. R. Walters (1973)
Webster, D. D.: Critical analysis of the disability in Parkinson's disease. Mod. Treatment 5, 257?282 (1968) / Mod. Treatment by D. D. Webster (1968)
Wålinder, J., Skott, A., Carlsson, A., Roos, B.-E.: Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. Arch. Gen. Psychiatry 33, 501?505 (1976) (10.1001/archpsyc.1976.01770040061011) / Arch. Gen. Psychiatry by J. Wålinder (1976)

Dates

Type	When
Created	20 years, 9 months ago (Nov. 11, 2004, 1:51 a.m.)
Deposited	6 years, 4 months ago (April 9, 2019, 6:39 p.m.)
Indexed	1 year, 1 month ago (July 31, 2024, 3:16 a.m.)
Issued	47 years, 8 months ago (Jan. 1, 1978)
Published	47 years, 8 months ago (Jan. 1, 1978)
Published Print	47 years, 8 months ago (Jan. 1, 1978)

Funders 0

None

BibTeX

@article{Gerlach_1978, title={Effect of baclofen on tardive dyskinesia}, volume={56}, ISSN={1432-2072}, url={http://dx.doi.org/10.1007/bf00431840}, DOI={10.1007/bf00431840}, number={2}, journal={Psychopharmacology}, publisher={Springer Science and Business Media LLC}, author={Gerlach, J. and Rye, T. and Kristjansen, P.}, year={1978}, pages={145–151} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        7,
        31
      ]
    ],
    "date-time": "2024-07-31T07:16:48Z",
    "timestamp": 1722410208635
  },
  "reference-count": 31,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1978,
            1,
            1
          ]
        ],
        "date-time": "1978-01-01T00:00:00Z",
        "timestamp": 252460800000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1978
      ]
    ]
  },
  "DOI": "10.1007/bf00431840",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        11,
        11
      ]
    ],
    "date-time": "2004-11-11T06:51:51Z",
    "timestamp": 1100155911000
  },
  "page": "145-151",
  "source": "Crossref",
  "is-referenced-by-count": 55,
  "title": "Effect of baclofen on tardive dyskinesia",
  "prefix": "10.1007",
  "volume": "56",
  "author": [
    {
      "given": "J.",
      "family": "Gerlach",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "T.",
      "family": "Rye",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "P.",
      "family": "Kristjansen",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "CR1",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "DOI": "10.1001/archpsyc.1973.01750340009001",
      "volume": "28",
      "author": "American College of Neuropsychopharmacology-Food and Drug Administration Task Force",
      "year": "1973",
      "unstructured": "American College of Neuropsychopharmacology-Food and Drug Administration Task Force: Neurological syndromes associated with antipsychotic drug use. Arch. Gen. Psychiatry 28, 463?467 (1973)",
      "journal-title": "Arch. Gen. Psychiatry"
    },
    {
      "key": "CR2",
      "doi-asserted-by": "crossref",
      "unstructured": "And\u00e9n, N. E., Dal\u00e9n, P., Johansson, B.: Baclofen and lithium in Huntington's chorea. Lancet 1973II, 93",
      "DOI": "10.1016/S0140-6736(73)93285-6"
    },
    {
      "key": "CR3",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "DOI": "10.1007/BF00502071",
      "volume": "297",
      "author": "N. E. And\u00e9n",
      "year": "1973",
      "unstructured": "And\u00e9n, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 297, 89?92 (1973)",
      "journal-title": "Naunyn Schmiedebergs Arch. Pharmacol."
    },
    {
      "key": "CR4",
      "doi-asserted-by": "crossref",
      "first-page": "310",
      "DOI": "10.1111/j.1600-0773.1977.tb02083.x",
      "volume": "40",
      "author": "N. E. And\u00e9n",
      "year": "1977",
      "unstructured": "And\u00e9n, N. E., Wachtel, H.: Biochemical effects of baclofen (?-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain. Acta Pharmacol. Toxicol. (Kbh.) 40, 310?320 (1977)",
      "journal-title": "Acta Pharmacol. Toxicol. (Kbh.)"
    },
    {
      "key": "CR5",
      "first-page": "32",
      "volume": "18",
      "author": "F. J. Ayd Jr.",
      "year": "1967",
      "unstructured": "Ayd, F. J., Jr.: Persistent dyskinesia: a neurologic complication of major tranquilizers. Med. Sci. 18, 32?40 (1967)",
      "journal-title": "Med. Sci."
    },
    {
      "key": "CR6",
      "first-page": "497",
      "volume-title": "GABA in nervous system function",
      "author": "T. N. Chase",
      "year": "1976",
      "unstructured": "Chase, T. N., Walters, J. R.: Pharmacologic approach to the manipulation of GABA mediated synaptic function man. In: GABA in nervous system function. E. Roberts and T. N. Chase, eds., pp. 497?513. New York: Raven Press 1976"
    },
    {
      "key": "CR7",
      "doi-asserted-by": "crossref",
      "first-page": "393",
      "DOI": "10.1016/0022-510X(75)90165-3",
      "volume": "24",
      "author": "L. E. Claveria",
      "year": "1975",
      "unstructured": "Claveria, L. E., Teychenne, P. F., Calne, D. B., Haskayne, L., Petrie, A., Pallis, C. A., Lodge-Patch, I. C.: Tardive dyskinesia treated with pimozide. J. Neurol. Sci. 24, 393?401 (1975)",
      "journal-title": "J. Neurol. Sci."
    },
    {
      "key": "CR8",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1016/0028-3908(76)90030-7",
      "volume": "15",
      "author": "B. Costall",
      "year": "1976",
      "unstructured": "Costall, B., Naylor, R. J., Pinder, R. M.: Mechanisms of dyskinesia in induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat. Neuropharmacology 15, 203?210 (1976)",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "CR9",
      "doi-asserted-by": "crossref",
      "first-page": "40",
      "DOI": "10.1176/ajp.124.8S.40",
      "volume": "124",
      "author": "G. E. Crane",
      "year": "1968",
      "unstructured": "Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am. J. Psychiatry 124, 40?48 (1968)",
      "journal-title": "Am. J. Psychiatry"
    },
    {
      "key": "CR10",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "DOI": "10.1192/bjp.122.4.395",
      "volume": "122",
      "author": "G. E. Crane",
      "year": "1973",
      "unstructured": "Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395?405 (1973)",
      "journal-title": "Br. J. Psychiatry"
    },
    {
      "key": "CR11",
      "doi-asserted-by": "crossref",
      "unstructured": "Davis, K. L., Hollister, L. E., Berger, P. A.: Baclofen in schizophrenia. Lancet 1976I, 1245",
      "DOI": "10.1016/S0140-6736(76)92198-X"
    },
    {
      "key": "CR12",
      "first-page": "177",
      "volume": "53",
      "author": "K. Fuxe",
      "year": "1975",
      "unstructured": "Fuxe, K., H\u00f6kfelt, T., Ljungdahl, \u00c5, Agnati, L., Johansson, O., de la Mora, M.: Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177?183 (1975)",
      "journal-title": "Med. Biol."
    },
    {
      "key": "CR13",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "DOI": "10.1007/BF00421217",
      "volume": "34",
      "author": "J. Gerlach",
      "year": "1974",
      "unstructured": "Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.) 34, 21?35 (1974)",
      "journal-title": "Psychopharmacologia (Berl.)"
    },
    {
      "key": "CR14",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1159/000468206",
      "volume": "11",
      "author": "J. Gerlach",
      "year": "1976",
      "unstructured": "Gerlach, J., Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int. Pharmacopsychiatry 11, 1?7 (1976)",
      "journal-title": "Int. Pharmacopsychiatry"
    },
    {
      "key": "CR15",
      "doi-asserted-by": "crossref",
      "first-page": "287",
      "DOI": "10.1111/j.1600-0447.1976.tb00122.x",
      "volume": "54",
      "author": "N. C. Gulman",
      "year": "1976",
      "unstructured": "Gulman, N. C., Bahr, B., Andersen, B., Eliassen, H. M.: A doubleblind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr. Scand 54, 287?293 (1976)",
      "journal-title": "Acta Psychiatr. Scand"
    },
    {
      "key": "CR16",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.1016/0006-8993(73)90037-1",
      "volume": "54",
      "author": "T. Hattori",
      "year": "1973",
      "unstructured": "Hattori, T., McGeer, P. L., Fibiger, H. H., McGeer, E. G.: On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. Brain Res. 54, 103?114 (1973)",
      "journal-title": "Brain Res."
    },
    {
      "key": "CR17",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "DOI": "10.1002/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I",
      "volume": "21",
      "author": "G. Honigfeld",
      "year": "1965",
      "unstructured": "Honigfeld, G., Klett, C. J.: The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia. J. Clin. Psychol. 21, 65?71 (1965)",
      "journal-title": "J. Clin. Psychol."
    },
    {
      "key": "CR18",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "DOI": "10.1001/archpsyc.1972.01750250081011",
      "volume": "27",
      "author": "H. Kazamatsuri",
      "year": "1972",
      "unstructured": "Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch. Gen. Psychiatry 27, 95?99 (1972a)",
      "journal-title": "Arch. Gen. Psychiatry"
    },
    {
      "key": "CR19",
      "doi-asserted-by": "crossref",
      "first-page": "100",
      "DOI": "10.1001/archpsyc.1972.01750250086012",
      "volume": "27",
      "author": "H. Kazamatsuri",
      "year": "1972",
      "unstructured": "Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate. Arch. Gen. Psychiatry 27, 100?103 (1972b)",
      "journal-title": "Arch. Gen. Psychiatry"
    },
    {
      "key": "CR20",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1111/j.1600-0447.1976.tb00090.x",
      "volume": "54",
      "author": "S. Korsgaard",
      "year": "1976",
      "unstructured": "Korsgaard, S.: Baclofen (Lioresal\u00ae) in the treatment of neurolepticinduced tardive dyskinesia. Acta Psychiatr. Scand. 54, 17?24 (1976)",
      "journal-title": "Acta Psychiatr. Scand."
    },
    {
      "key": "CR21",
      "first-page": "31",
      "volume": "7",
      "author": "R. A. Lahti",
      "year": "1974",
      "unstructured": "Lahti, R. A., Losey, E. G.: Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA. Res. Commun. Chem. Pathol. Pharmacol. 7, 31?40 (1974)",
      "journal-title": "Res. Commun. Chem. Pathol. Pharmacol."
    },
    {
      "key": "CR22",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "DOI": "10.1192/bjp.129.2.114",
      "volume": "129",
      "author": "M. Linnoila",
      "year": "1976",
      "unstructured": "Linnoila, M., Viukari, M., Hietala, O.: Effects of sodium valproate on tardive dyskinesia. Br. J. Psychiatry 129, 114?119 (1976)",
      "journal-title": "Br. J. Psychiatry"
    },
    {
      "key": "CR23",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "DOI": "10.1016/0014-4886(75)90045-X",
      "volume": "46",
      "author": "G. M. McKenzie",
      "year": "1975",
      "unstructured": "McKenzie, G. M., Viik, K.: Chemically induced choreiform activity: antagonism by GABA and EEG patterns. Exp. Neurol. 46, 229?243 (1975)",
      "journal-title": "Exp. Neurol."
    },
    {
      "key": "CR24",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "DOI": "10.1016/0028-3908(76)90058-7",
      "volume": "15",
      "author": "S. R. Naik",
      "year": "1976",
      "unstructured": "Naik, S. R., Guidotto, A., Costa, E.: Central GABA receptor agonists: comparison of muscimol and baclofen. Neuropharmacology 15, 479?484 (1976)",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "CR25",
      "doi-asserted-by": "crossref",
      "first-page": "799",
      "DOI": "10.2466/pr0.1962.10.3.799",
      "volume": "10",
      "author": "J. E. Overall",
      "year": "1962",
      "unstructured": "Overall, J. E., Gorham, D. R.: The brief psychiatric rating scale. Psychol. Rep. 10, 799?812 (1962)",
      "journal-title": "Psychol. Rep."
    },
    {
      "key": "CR26",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "DOI": "10.1056/NEJM197302152880703",
      "volume": "228",
      "author": "T. L. Perry",
      "year": "1973",
      "unstructured": "Perry, T. L., Hansen, S., Kloster, M.: Huntington's chorea: deficiency of ?-aminobutyric acid in brain. N. Engl. J. Med. 228, 337?342 (1973)",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "CR27",
      "doi-asserted-by": "crossref",
      "unstructured": "Simpson, G. M., Branchey, M. H., Shrivastava, R. K.: Baclofen in schizophrenia. Lancet 1976I, 967?968",
      "DOI": "10.1016/S0140-6736(76)92749-5"
    },
    {
      "key": "CR28",
      "doi-asserted-by": "crossref",
      "unstructured": "Villeneuve, A., B\u00f6sz\u00f6rm\u00e9nyi, Z: Treatment of drug-induced dyskinesias. Lancet 1970I, 353?354",
      "DOI": "10.1016/S0140-6736(70)90724-5"
    },
    {
      "key": "CR29",
      "first-page": "630",
      "volume": "186",
      "author": "J. R. Walters",
      "year": "1973",
      "unstructured": "Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigroneostriatal pathways. J. Pharmacol. Exp. Ther. 186, 630?639 (1973)",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "CR30",
      "first-page": "257",
      "volume": "5",
      "author": "D. D. Webster",
      "year": "1968",
      "unstructured": "Webster, D. D.: Critical analysis of the disability in Parkinson's disease. Mod. Treatment 5, 257?282 (1968)",
      "journal-title": "Mod. Treatment"
    },
    {
      "key": "CR31",
      "doi-asserted-by": "crossref",
      "first-page": "501",
      "DOI": "10.1001/archpsyc.1976.01770040061011",
      "volume": "33",
      "author": "J. W\u00e5linder",
      "year": "1976",
      "unstructured": "W\u00e5linder, J., Skott, A., Carlsson, A., Roos, B.-E.: Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. Arch. Gen. Psychiatry 33, 501?505 (1976)",
      "journal-title": "Arch. Gen. Psychiatry"
    }
  ],
  "container-title": "Psychopharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00431840.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/BF00431840/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00431840",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        4,
        9
      ]
    ],
    "date-time": "2019-04-09T22:39:46Z",
    "timestamp": 1554849586000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/BF00431840"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1978
      ]
    ]
  },
  "references-count": 31,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1978
        ]
      ]
    }
  },
  "alternative-id": [
    "BF00431840"
  ],
  "URL": "http://dx.doi.org/10.1007/BF00431840",
  "relation": {},
  "ISSN": [
    "0033-3158",
    "1432-2072"
  ],
  "subject": [],
  "container-title-short": "Psychopharmacology",
  "published": {
    "date-parts": [
      [
        1978
      ]
    ]
  }
}